Navigation Links
DaVita Clinical Research Appoints Mahesh Krishnan as Vice President
Date:7/13/2009

DENVER, July 13 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced Mahesh Krishnan, MD, MPH has been appointed to DaVita Clinical Research(R) as Vice President for Research, effective July 13, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

DaVita Clinical Research is recognized as a leader in clinical trials for drugs and devices. Krishnan will be responsible for leadership for Medical Informatics, publications, DaVita(R) internal research initiatives, serving as primary clinical liaison for all Research partners, and acting as a member of the Office of the Chief Medical Officer (OCMO).

"Dr. Krishnan has proven himself as one of the best and brightest minds in nephrology and we are thrilled to welcome him to the DaVita Village," said Dr. Allen R. Nissenson, Chief Medical Officer for DaVita. "His expertise will help DaVita Clinical Research in its continuing mission to advance the knowledge and practice of kidney care, and further OCMO's relentless pursuit of quality(TM) for kidney patients."

Dr. Krishnan brings more than 15 years of healthcare industry experience to DaVita. Previously, he served as the Executive Director of Medical Policy, Nephrology Therapeutic Area Head for Global Health Economics, and Global Development Leader for Epogen(R) at AMGEN Inc. During his tenure with AMGEN, he played an important role in the 2007 FDA Cardio Renal Drug Advisory Panel for Erythropoietic Stimulating Agents, served as the primary contact for the Dialysis Outcomes Practice Patterns Study, and led many important research projects focused on observational research and dialysis care. He was the founder and managing partner of the Clinical Consulting and Research Center in Fairfax, VA, and prior to that, was in practice in Northern Virginia for nearly five years.

After receiving his bachelor's degree in premedicine from Penn State University, Krishnan earned his medical degree from The Jefferson Medical College at Thomas Jefferson University. He also holds a master's degree in Public Health from Johns Hopkins University and completed the Health Management Program for Community-Based Nephrologists at Duke University's Fuqua School of Business. Additionally, he is currently working towards an MBA in Medical Services Management at the Johns Hopkins Carey School of Business in Baltimore, MD.

Dr. Krishnan is a member of the American College of Physicians, American Medical Association, American Society of Nephrology and National Kidney Foundation. He currently serves on the editorial board of Nephrology News and Issues and his writing has been published nearly 20 times in renal care and research publications around the world.

DaVita and DaVita Clinical Research are registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. Recognized as the only FORTUNE 500(R) company on WorldBlu's annual List of Most Democratic Workplaces(TM), DaVita manages more than 1,475 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 114,000 patients - nearly one-in-three of all dialysis patients in the United States. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials and its community programs, please visit www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DaVitas Award-Winning Training Program for New Teammates Reaches Milestone With 100th DaVita Academy in Baltimore, Maryland
2. DaVita Celebrates the Opening of Its 1,500th Outpatient Kidney Care Clinic in the United States
3. DaVita.com Provides Easy Recipes to Plan Your Fathers Day Dinner
4. DaVita Launches First Corporate Social Responsibility Report With Nationwide Community Service Blitz
5. DaVita Named One of Best Companies to Work for in Colorado
6. DaVita Named to List of Best Places to Work in Los Angeles by the Los Angeles Business Journal
7. DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
8. DaVita Commends Kidney Care Partners for Launch of PEAK Campaign
9. DaVitas Kidney Calculator iPhone App Downloaded in 24 Countries
10. DaVita Extends Lease to Maintain Strong Business Presence in Tacoma
11. Pamela M. Arway Joins DaVita Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... Frederick, Maryland (PRWEB) , ... June 24, 2016 ... ... Mid-Atlantic Angels is actively feeding the Frederick area economy by obtaining investment capital ... support over the past 2½ years that have already resulted in more than ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
(Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... a number of ,world firsts,: , TwinLink™ ...
Breaking Medicine Technology: